← Back to Search

Survivorship Care Planning + Telehealth Education for Cancer

N/A
Waitlist Available
Led By Eric Chow
Research Sponsored by Fred Hutchinson Cancer Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Cancer survivors who have completed curative therapy within the past 5 years (may still currently be on long-term/targeted non-cytotoxic agent maintenance therapy, e.g., tamoxifen or aromatase inhibitors for breast cancer survivors; androgen deprivation therapy for prostate cancer survivors)
English or Spanish speakers
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8 weeks
Awards & highlights

Study Summary

This trial is studying how well self-generated survivorship care plans and telehealth education work in improving knowledge and self-efficacy in cancer survivors living in rural areas.

Who is the study for?
This trial is for adult cancer survivors who finished curative therapy within the last 5 years and have a history of lymphoma, breast, colorectal, lung, or prostate cancer. They must be able to do study tasks like questionnaires and agree to randomization. Participants need access to a phone and can receive materials electronically. It excludes those on palliative care or without telephone access.Check my eligibility
What is being tested?
The IMPACT Study tests if self-generated survivorship care plans combined with telehealth education improve knowledge and self-efficacy in rural cancer survivors. The goal is better transition from oncology to primary care and improved communication between healthcare providers.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional side effects are not applicable. However, participants may experience stress or discomfort when discussing their cancer experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I finished my cancer treatment within the last 5 years and may still be on maintenance therapy.
Select...
I speak English or Spanish.
Select...
I had cancer (lymphoma, breast, colorectal, lung, or prostate) as an adult.
Select...
I can understand and agree to the study's details.
Select...
I am willing to be assigned to a treatment group by chance.
Select...
I can complete all study tasks, including questionnaires.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accuracy of survivors' self-generated survivorship care plans (SCPs) in relation to those based on medical record abstraction
Initial participation rate of cancer survivors identified from community-based practices
Proportion of survivors who complete the follow-up questionnaire within the study time period
+2 more
Secondary outcome measures
Local oncology clinics' attitudes towards survivorship care implementation
PCP self-efficacy towards survivorship care
Participant perceived self-efficacy: questionnaire using the PROMIS Global 10 and health related self-efficacy scales
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm II (patient-generated SCP, educational counseling)Experimental Treatment3 Interventions
Patients receive a self-generated SCP as in Arm I. Patients also receive a 30-minute telephone-based educational counseling session on survivorship care administered by trained lay health counselors.
Group II: Arm I (patient-generated SCP)Active Control2 Interventions
Patients receive a self-generated SCP (i.e., generated from baseline questionnaire responses).

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,609 Previous Clinical Trials
40,915,446 Total Patients Enrolled
1,376 Trials studying Lymphoma
381,384 Patients Enrolled for Lymphoma
Fred Hutchinson Cancer Research CenterLead Sponsor
443 Previous Clinical Trials
148,181 Total Patients Enrolled
93 Trials studying Lymphoma
5,933 Patients Enrolled for Lymphoma
Fred Hutchinson Cancer CenterLead Sponsor
555 Previous Clinical Trials
1,334,526 Total Patients Enrolled
100 Trials studying Lymphoma
6,337 Patients Enrolled for Lymphoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being enrolled into this research project presently?

"This research trial, initially posted in February 2020 and last edited on November 2022, is not currently enrolling patients. Nonetheless, there are 8,380 other medical studies actively seeking participants at this juncture."

Answered by AI

What is the overall aim of this study?

"This clinical trial's primary aim is to assess the accuracy of patients' self-generated survivorship care plans compared to those based on medical record abstraction over an 8 week window. Secondary outcomes include evaluating participant perceived self-efficacy, knowledge about their cancer survivorship and PCP self-efficacy towards providing such treatment via a questionnaire using the PROMIS Global 10 and related health scales."

Answered by AI
~47 spots leftby Jun 2025